Home/Filings/4/0001178913-22-000163
4//SEC Filing

Ellis Sean 4

Accession 0001178913-22-000163

CIK 0001638097other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:02 PM ET

Size

5.1 KB

Accession

0001178913-22-000163

Insider Transaction Report

Form 4
Period: 2022-01-18
Ellis Sean
Director
Transactions
  • Purchase

    Ordinary Shares, par value NIS 0.0000769 per share

    2022-01-18$2.81/sh+10,000$28,05010,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.85, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904752

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:02 PM ET
Size
5.1 KB